What is in the future for fibromyalgia therapy?

The key to unlocking the mystery of fibromyalgia has yet to be found. Research scientists have been studying numerous viruses as potential causes for fibromyalgia. Identification of an infectious agent or toxin which causes the disease may one day lead to a laboratory test which can help doctors diagnose fibromyalgia. Until further research uncovers the exact cause of the disease, specific treatment aimed at a cure remains unattainable.

New drugs may be developed that block substance P or nerve growth factor to relieve pain of fibromyalgia. Many fibromyalgia patients can be helped by improved patient education, proper exercise, and medications. With ongoing research, the future will certainly improve for those affected by fibromyalgia.

Recent research has suggested that drugs that block more than one brain nerve transmitter, such as duloxetine (Cymbalta), can be effective in treating fibromyalgia. Duloxetine has been effective in treating depression and relieving pain in persons with depression. More research is under way to evaluate the potential of these new treatments.

The FDA has approved Lyrica as the first drug treatment for fibromyalgia. It reduces pain and improves daily functions for some patients. The drug's most common side effects include mild to moderate dizziness and sleepiness. Lyrica can also cause blurry vision and trouble concentrating. The FDA advises patients to talk to their doctor about whether the use of Lyrica may impair their ability to drive.